• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Clarinex (desloratadine) Tablets, Clarinex (desloratadine) Oral Solution, and Clarinex (desloratadine) Reditabs

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

April 2014

Summary View

6 ADVERSE REACTIONS

6.2 Post-Marketing Experience
  • added ....movement disorders (including dystonia, tics, and extrapyramidal symptoms)